The recent suspension of Dr. Syed Maqbool, a respected interventional cardiologist at Government Medical College in Anantnag, has ignited a firestorm of controversy within the medical community of Jammu and Kashmir. The state health authorities acted following an internal investigation that accused Dr. Maqbool of procedural irregularities involving 103 heart surgeries. Specifically, officials claim he performed an advanced life-saving technique known as Left Bundle Branch Area Pacing (LBBAP) while billing them under the “dual-chamber pacemaker” category within the Ayushman Bharat PMJAY insurance framework. The government argues that this miscategorization allowed patients to claim benefits for a procedure not officially covered by the scheme, labeling the actions as a serious administrative and technical violation.
The situation grew more complex—and controversial—when a technical report, purportedly stemming from the Sher-i-Kashmir Institute of Medical Sciences (SKIMS), suggested that many of these surgical interventions were unnecessary, citing that 27 out of 55 reviewed patients actually had normal ventricular function. However, this assertion has been met with skepticism and pushback from senior officials at SKIMS, who have distanced themselves from the document. They suggest that the government bypassed standard institutional channels, instead seeking private opinions from retired cardiologists rather than conducting a transparent, peer-reviewed evaluation. This has led many to question the impartiality of the inquiry, especially since Dr. Maqbool maintains that his detailed, evidence-based rebuttals were pointedly excluded from the final report presented to the health department.
Dr. Maqbool remains firm in his defense, asserting that he operated with the best interests of his patients at heart. He has formally challenged the findings and expressed unwavering faith that the truth will emerge as the legal and administrative process unfolds. From his perspective, the “irregularities” cited by the government were, in reality, logistical workarounds born out of necessity. By coding the LBBAP procedures as dual-chamber implantations, he was reportedly trying to leverage existing insurance structures to ensure that impoverished patients could access a superior, modern medical technique that otherwise would have been financially out of reach. In this view, the bureaucratic system, rather than the surgeon, was the true barrier to patient care.
This case has effectively pulled the curtain back on a significant gap between medical innovation and administrative policy. LBBAP represents a significant leap forward in cardiology, offering better clinical outcomes than the conventional pacing methods recognized by older government insurance categories. Medical experts, including Dr. Khalil Kanjwal—a prominent Michigan-based electrophysiologist—have stepped into the fray to support the use of LBBAP. Dr. Kanjwal argued that such techniques should arguably be the standard of care, stating that LBBAP provides clear physiological benefits over traditional methods. By forcing doctors to choose between using outdated, less effective technology or navigating a restrictive billing code, the healthcare system may be inadvertently penalizing those who aim for the highest standard of patient outcomes.
The core of the dispute highlights a recurring struggle in public healthcare: the tension between rigid, cost-controlled insurance schemes and the evolving nature of medical science. When cutting-edge treatments like LBBAP emerge, they often outpace the government’s ability to update its billing codes. In this instance, the cost of specialized equipment for the surgery was high; had Dr. Maqbool confined his practice to the officially “covered” archaic methods, his patients would have received inferior care, while those needing the modern procedure would have faced complete financial ruin. Therefore, what the state characterizes as a fraudulent attempt to manipulate insurance funds, many in the medical fraternity see as an act of compassionate advocacy—finding a way to bridge the gap between human need and an inflexible, outdated reimbursement structure.
As the matter remains under consideration, the medical community in Kashmir is watching closely, sensing that the outcome will set a vital precedent for how physicians are allowed to practice in a fast-changing field. The suspension of such a high-profile cardiologist has forced a public conversation on whether bureaucrats or doctors should define the boundaries of “covered” procedures. While accountability is essential in any government-funded health scheme, there is a tangible fear that punishing innovation will stifle medical progress and leave patients with only the bare minimum of care. Ultimately, the industry is waiting to see if the authorities will move toward reforming these rigid insurance silos or if they will continue to prioritize administrative compliance over the life-altering benefits of clinical innovation.